Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 -0.4 (-0.26%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 12:30AM GMT
Release Date Price: $106.73 (+0.22%)
Lisa Christine Gill
JP Morgan Chase & Co, Research Division - Senior Publishing Analyst

Good afternoon, and welcome to the afternoon session. My name is Lisa Gill. I'm the health care technology and distribution analyst with J.P. Morgan. With us this afternoon, we have Quest Diagnostics. Presenting for Quest is CEO, Steve Rusckowski. After the presentation, we will take questions across the hall in the Borgia Room.

Steve?

Stephen H. Rusckowski
Quest Diagnostics Incorporated - Chairman, President & CEO

Thank you, Lisa. Good afternoon, everyone. Pleasure to be here. And I'd like to start with the safe harbor statement.

And to start, I'd like to share what we do at Quest Diagnostics, which is we are the world's largest laboratory, but what we believe is that we're really in the business of diagnostic information services. We think there's more we can do with our data. There's more we can do with the content around that data. And there's more business -- more business and more opportunities to apply that and be able to -- to be able to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot